Precision medicine, using targeted gene sequencing, tailors cancer treatments by identifying unique genomic changes. 1 Recent advancements in next-generation sequencing (NGS) have revealed extensive somatic and germline mutations in solid tumors, leading to the categorization of tumor sub-types and facilitating the development of targeted therapies. 1 Targeted NGS assays play a crucial role in the accurate detection of clinically relevant genetic variants in solid tumors, enabling personalized therapies. 2 Wondering how NGS can revolutionize your understanding of solid tumors? Join our panel of experts, Dr. Shaikhali Barodawala, Dr. Anita Ramesh, Dr.
Kriti Chadha, Dr. Satish Kamat, Dr. Nikhil Himthani, Dr. Fahad Afzal, and Dr. Bharat Patodiya, along with our international speaker Dr. Luca Quagliata in a special session to learn more about the “ Recent Advances in Precision Oncology -…
